The Journal of Neuroscience, July 8, 2009, 29(27):8743-8751; doi:10.1523/JNEUROSCI.2294-09.2009
Previous Article | Next Article 
Neurobiology of Disease
Phosphorylation of Prion Protein at Serine 43 Induces Prion Protein Conformational Change
Paresa N. Giannopoulos,1
Catherine Robertson,2,3
Julie Jodoin,1,4
Hemant Paudel,1,4
Stephanie A. Booth,2,3 and
Andrea C. LeBlanc1,4
1The Bloomfield Centre for Research in Aging, Lady Davis Institute for Medical Research, The Sir Mortimer B. Davis Jewish General Hospital, Montréal, Québec H3T 1E2, Canada, 2Molecular Pathobiology, National Microbiology Laboratory, Winnipeg, Manitoba R3E 3R2, Canada, 3Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada, and 4Department of Neurology and Neurosurgery, McGill University, Montréal, Québec H3A 2T5, Canada
Correspondence should be addressed to Dr. Andréa LeBlanc, The Bloomfield Centre for Research in Aging, Lady Davis Institute for Medical Research, The Sir Mortimer B. Davis Jewish General Hospital, 3755 Chemin Côte Ste-Catherine, Montréal, QC H3T 1E2, Canada. Email: andrea.leblanc{at}mcgill.ca
The cause of the conformational change of normal cellular prion protein (PrP) into its disease-associated form is unknown. Posttranslational modifications, such as glycosylation, acetylation, S-nitrosylation, and phosphorylation, are known to induce protein conformational changes. Here, we investigated whether phosphorylation could induce the conformational change of PrP because PrP contains several kinase motifs and has been found recently in the cytosol, in which kinases generally reside. Neuronal cyclin-dependent kinase 5 (Cdk5) phosphorylated recombinant PrP23–231 at serine 43 (S43) in an in vitro kinase assay. Cdk5-phosphorylated PrP became proteinase K resistant, formed Congo Red-positive fibrils, and formed aggregates that were immunostained with anti-PrP and anti-phospho-PrPS43 (anti-pPrPS43). pPrPS43 was detected in PrP/Cdk5/p25 cotransfected N2a cells. Roscovitine inhibition of Cdk5 activity or transfection of N2a cells with mutant PrP S43A eliminated the anti-pPrPS43-immunopositive protein. Alkaline phosphatase-sensitive and proteinase K-resistant pPrPS43 immunoreactivity was observed in scrapie-infected but not control-injected mice brains. These results raise the possibility that phosphorylation could represent a physiological mechanism of PrP conversion in vivo.
Received May 15, 2009;
accepted June 3, 2009.
Correspondence should be addressed to Dr. Andréa LeBlanc, The Bloomfield Centre for Research in Aging, Lady Davis Institute for Medical Research, The Sir Mortimer B. Davis Jewish General Hospital, 3755 Chemin Côte Ste-Catherine, Montréal, QC H3T 1E2, Canada. Email: andrea.leblanc{at}mcgill.ca